The global economic landscape is undergoing a seismic shift as countries brace for potential US tariffs. Since the dawn of the Trump Administration in 2017, the US share of global trade has been on the decline, even as its GDP share has risen. This paradox is driven by robust US economic growth and soaring equity valuations, reflecting investor confidence in American innovation.


However, the world is not standing still. Non-US trade is flourishing, with countries actively signing new trade agreements to reduce reliance on the US. The European Union, for instance, has recently finalized deals with South American nations and is in talks with Australia and Indonesia, as reported by FT. Meanwhile, China is pivoting towards Asia-Pacific partnerships and engaging with Latin American countries.


The US Economy Remains Strong

Despite these global shifts, the US economy continues to show resilience. According to recent data from the Bureau of Economic Analysis, the US GDP grew by 2.8% in 2024, driven by a surge in consumer spending, particularly on durable goods.


Yet, there are signs of caution. Business investment fell, and trade made a negative contribution to GDP growth in the fourth quarter. The looming threat of tariffs could further complicate matters, potentially leading to higher consumer prices and impacting export growth.


US Federal Reserve Keeps Policy Unchanged

The Federal Reserve, as expected, has kept interest rates steady. In a recent press conference, Fed Chair Powell highlighted that while the labor market has cooled, inflation remains “elevated.” This cautious stance led to a drop in equity prices and a rise in bond yields, reflecting investor sentiment.


Eurozone Economy Stagnates While ECB Cuts Rates

Across the Atlantic, the Eurozone economy is facing stagnation. Recent reports from Eurostat show no growth in the fourth quarter of 2024. The European Central Bank (ECB) responded by cutting interest rates, aiming to boost activity amid ongoing economic headwinds.


ECB President Lagarde noted that while manufacturing is weak, services remain strong. However, potential US tariffs pose a risk, potentially impacting the Eurozone’s growth trajectory.


As the global economic narrative unfolds, the world watches closely, anticipating the US’s next move on tariffs and its ripple effects on global trade and economic stability.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.